Atlas Trials

A Study of Concurrent Chemoradiotherapy Followed by Cadonilimab(AK104) for Newly Diagnosed Local Advanced Cervical Cancer

Clinical trial NCT06251388 · RECRUITING

Trial details

NCT number
NCT06251388
Sponsor
West China Second University Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Cervical Cancer
Start date
2024-02-20
Primary completion
2025-05-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.